BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
711 results:

  • 1. Anxiety Levels in Brazilian Women with Metastatic Breast cancer Undergoing Palliative Chemotherapy: A Prospective Study.
    Marcondes L; Silva LDS; Ribeiro CO; Oshiro NN; Nogueira LA; Guimaraes PRB; Kalinke LP
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1135-1141. PubMed ID: 38679972
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Common misconceptions and myths about ovarian cancer causation: a national cross-sectional study from palestine.
    Elshami M; Jaber I; Alser M; Al-Slaibi I; Jabr H; Ubaiat S; Tuffaha A; Khader S; Khraishi R; Arafeh ZA; Al-Madhoun S; Alqattaa A; Yaseen A; El Hadi AA; Barhoush O; Hijazy M; Eleyan T; Alser A; Hziema AA; Shatat A; Almakhtoob F; Mohamad B; Farhat W; Abuamra Y; Mousa H; Adawi R; Musallam A; Albarqi SI; Abu-El-Noor N; Bottcher B
    BMC Public Health; 2024 Apr; 24(1):1027. PubMed ID: 38609950
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast cancer.
    Leon-Ferre RA; Jonas SF; Salgado R; Loi S; de Jong V; Carter JM; Nielsen TO; Leung S; Riaz N; Chia S; Jules-Clément G; Curigliano G; Criscitiello C; Cockenpot V; Lambertini M; Suman VJ; Linderholm B; Martens JWM; van Deurzen CHM; Timmermans AM; Shimoi T; Yazaki S; Yoshida M; Kim SB; Lee HJ; Dieci MV; Bataillon G; Vincent-Salomon A; André F; Kok M; Linn SC; Goetz MP; Michiels S;
    JAMA; 2024 Apr; 331(13):1135-1144. PubMed ID: 38563834
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients.
    Liu Q; Li Z; Zhou H; Cao D; Yang J; Shen K; Lang J
    Orphanet J Rare Dis; 2024 Mar; 19(1):132. PubMed ID: 38515195
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours.
    Deng M; Yang R; Sun Q; Zhang J; Miao J
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):629-642. PubMed ID: 38501576
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
    Yaacoub S; Hajj L; Khairallah A
    BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Platinum desensitization therapy and its impact on the prognosis of ovary high-grade serous adenocarcinoma: a real world-data.
    Li K; Yin R
    Front Immunol; 2024; 15():1346464. PubMed ID: 38312839
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls.
    Gultekin SC; Cakir AB; Guc ZG; Ozalp FR; Keskinkilic M; Yavuzsen T; Yavuzsen HT; Karadibak D
    Support Care Cancer; 2024 Jan; 32(2):119. PubMed ID: 38252310
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia.
    Wu P; Shan W; Xue Y; Wang L; Liu S; Chen X; Luo X
    Front Endocrinol (Lausanne); 2023; 14():1286724. PubMed ID: 38250737
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
    Wang Y; Dackus GMHE; Rosenberg EH; Cornelissen S; de Boo LW; Broeks A; Brugman W; Chan TWS; van Diest PJ; Hauptmann M; Ter Hoeve ND; Isaeva OI; de Jong VMT; Jóźwiak K; Kluin RJC; Kok M; Koop E; Nederlof PM; Opdam M; Schouten PC; Siesling S; van Steenis C; Voogd AC; Vreuls W; Salgado RF; Linn SC; Schmidt MK
    BMC Med; 2024 Jan; 22(1):9. PubMed ID: 38191387
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer.
    Khanmammadov NJ; Doğan İ; Okay NS; Azizy A; Saip P; Aydiner A
    Medicine (Baltimore); 2024 Jan; 103(1):e36750. PubMed ID: 38181291
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Phthalimide-tethered isatins as novel poly(ADP-ribose) polymerase inhibitors: Design, synthesis, biological evaluations, and molecular modeling investigations.
    El Hassab MA; El-Hafeez AAA; Almahli H; Elsayed ZM; Eldehna WM; Hassan GS; Abou-Seri SM
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300599. PubMed ID: 38100160
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Significance of Ultra-Radical Surgery in Extensive Metastatic ovarian Growing Teratoma Syndrome.
    Li S; Wang T; Du H; Tang H; Zhang T; Zhang R; Zhang X; Yang J
    Oncology; 2023; 101(12):773-781. PubMed ID: 38096801
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ovarian cancer disease burden decreased in the United States from 1975 to 2018: A joinpoint and age-period-cohort analysis.
    He J; Hu Q
    Medicine (Baltimore); 2023 Dec; 102(48):e36029. PubMed ID: 38050303
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
    Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
    Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Olaparib plus Durvalumab, with or without Bevacizumab, as treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed ovarian cancer: A Phase II Multi-Cohort Study.
    Drew Y; Kim JW; Penson RT; O'Malley DM; Parkinson C; Roxburgh P; Plummer R; Im SA; Imbimbo M; Ferguson M; Rosengarten O; Steeghs N; Kim MH; Gal-Yam E; Tsoref D; Kim JH; You B; De Jonge M; Lalisang R; Gort E; Bastian S; Meyer K; Feeney L; Baker N; Ah-See ML; Domchek SM; Banerjee S;
    Clin Cancer Res; 2024 Jan; 30(1):50-62. PubMed ID: 37939124
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
    Durán-Martínez M; Gómez-Dueñas G; Rodriguez-Ortíz L; Sanchez-Hidalgo JM; Gordón-Suárez A; Casado-Adam Á; Rufián-Peña S; Valenzuela-Molina F; Rufián-Andujar B; Vázquez-Borrego MC; Romero-Ruiz A; Briceño-Delgado J; Arjona-Sánchez Á
    Surg Endosc; 2024 Jan; 38(1):66-74. PubMed ID: 37903884
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant cancers with B7-H4 Expression.
    Gitto SB; Whicker M; Davies G; Kumar S; Kinneer K; Xu H; Lewis A; Mamidi S; Medvedev S; Kim H; Anderton J; Tang EJ; Ferman B; Coats S; Wilkinson RW; Brown E; Powell DJ; Simpkins F
    Clin Cancer Res; 2024 Apr; 30(8):1567-1581. PubMed ID: 37882675
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer.
    Jorgensen K; Denham C; Kanbergs A; Wu CF; Nitecki R; Agusti N; Meernik C; Melamed A; Rauh-Hain JA
    Gynecol Oncol; 2023 Nov; 178():60-68. PubMed ID: 37801736
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
    Sobocan M; Chandrasekaran D; Sideris M; Blyuss O; Fierheller C; Kalra A; Sia J; Miller RE; Mills-Baldock T; Crusz SM; Sun L; Evans O; Robbani S; Jenkins LA; Ahmed M; Kumar A; Quigley M; Lockley M; Faruqi A; Casey L; Brockbank E; Phadnis S; Trevisan G; Singh N; Legood R; Manchanda R
    BJOG; 2024 May; 131(6):848-857. PubMed ID: 37752678
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 36.